Matching geography Reports matching your search in: Join Alert Me now!Receive bi-weekly email alerts on new market research Sign up today!
|
Regulation & Policy: market research reports
Reports in this category will address the important role of regulation and policy in the healthcare market. As a highly regulated industry in most countries, healthcare marketers need to be aware of regulations in the countries where they sell products. Regulation will commonly refer to the actions of administrative bodies and existing laws, where as Policy would include potential laws and partial actions of state legislatures or congress. Given that regulatory activity in the healthcare industry is intense and that policy debates are numerous, pharmaceutical or device markets need an awareness of what laws apply to their products.
In the United States drugs, diagnostics and medical devices are regulated by the Food and Drug Administration (FDA). The FDA is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments. The FDA is responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), veterinary products, and cosmetics.
The FDA derives its power from the Food, Drug and Cosmetic Act,[7] (Passed in 1938 and amended since) and are codified in Title 21, Chapter 9 of the United States Code. Some other laws that impact the FDA’s authority is Public Health Service Act, parts of the Controlled Substances Act, the Federal Anti-Tampering Act.
Regulation & Policy market research reports and industry analysis
Central America Pharmaceuticals and Healthcare Report Q1 2013
1/16/2013 | published by: Business Monitor International
... opportunities forgeneric drugmakers from neighbouring Latin American countries and India. We highlight that Costa Ricaand Panama can be the premier countries in the region for foreign drugmakers to expand their presence. Headline Expenditure Projections Pharmaceuticals: ...
|
more...
|
$1,175.00
|
Indonesia Pharmaceuticals & Healthcare Industry 2H12
1/14/2013 | published by: Emerging Markets Direct Reports
... support and pharmaceutical trade. It also covers the market trends and outlook, regulatory changes, counterfeit drugs, industry SWOT analysis and market outlook, plus profile, comparative matrix and SWOT analysis of the leading players: PT Kalbe ...
|
more...
|
$450.00
|
Botanical and Plant-Derived Drugs: Global Markets
1/1/2013 | published by: BCC Research
... from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017 A focus on legal, prescription-required therapeutic medicines sold in the open market; the study does not specifically cover herbals generally ...
|
more...
|
$4,850.00
|
|
|
$3,500.00
|
Healthcare, Regulatory and Reimbursement Landscape - Denmark
12/12/2012 | published by: GlobalData
... on Denmark`s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and healthcare infrastructure. Most importantly, it provides valuable insights ...
|
more...
|
$1,995.00
|
Healthcare, Regulatory and Reimbursement Landscape - Venezuela
12/5/2012 | published by: GlobalData
... on the healthcare, regulatory and reimbursement landscape of Venezuela. The report identifies the key trends in the healthcare market of Venezuela. The report also provides insights into the demographic, regulatory and reimbursement landscapes and the ...
|
more...
|
$1,995.00
|
Healthcare, Regulatory and Reimbursement Landscape - Israel
12/5/2012 | published by: GlobalData
... healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into ...
|
more...
|
$1,995.00
|
Healthcare, Regulatory and Reimbursement Landscape - Morocco
11/30/2012 | published by: GlobalData
... healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the Morocco healthcare market, as well as providing insights on the demographic, regulatory, and reimbursement landscape, and the healthcare infrastructure of Morocco. Most ...
|
more...
|
$1,995.00
|
Healthcare, Regulatory and Reimbursement Landscape - Turkey
11/30/2012 | published by: GlobalData
... Turkey’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights ...
|
more...
|
$1,995.00
|
Healthcare, Regulatory and Reimbursement Landscape - The Netherlands
11/20/2012 | published by: GlobalData
... and analysis regarding the healthcare, regulatory, and reimbursement landscape in the Netherlands. It identifies key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape, and the healthcare infrastructure. Most ...
|
more...
|
$1,995.00
|
|
|
$2,600.00
|
|
|
$3,500.00
|
|
|
$3,500.00
|
China Pharmaceuticals & Health Care Industry 2H12
11/6/2012 | published by: Emerging Markets Direct Reports
... trends and outlook, social health care insurance system, traditional Chinese medicine, over-the-counter and vaccines, plus the profile, comparative matrix and SWOT analysis of the industry leading players: Shanghai Pharmaceuticals Holding Co. Ltd., China National Accord ...
|
more...
|
$480.00
|
|
|
$1,200.00
|
Chinese CRO Company Report - Tigermed Consulting Co., Ltd.
11/1/2012 | published by: JZMed, Inc.
... as competent as those top tier players in the same service sector of the global pharma outsourcing industry. To help global pharma outsourcing companies and professional service providers as well as venture capital investors better ...
|
more...
|
$395.00
|
Market Access Taiwan
11/1/2012 | published by: JustPharmaReports.com
... be modified and the importance of health technology assessment (HTA) reaffirmed. The Cross-Strait Co-operation Agreement on Medicine and Public Health Affairs with mainland China might be of even greater significance in the longer term as ...
|
more...
|
$1,420.00
|
Chinese CRO Company Report - Beijing Genomic Institute (BGI)
11/1/2012 | published by: JZMed, Inc.
... as competent as those top tier players in the same service sector of the global pharma outsourcing industry. To help global pharma outsourcing companies and professional service providers as well as venture capital investors better ...
|
more...
|
$395.00
|
Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia
10/31/2012 | published by: GlobalData
... the Saudi Arabian healthcare, regulatory, and reimbursement landscape, this report identifies the key trends in the healthcare market, and provides insights on the demographic, regulatory, and reimbursement landscape, and healthcare infrastructure. Most importantly, the report ...
|
more...
|
$1,995.00
|
Global Pharmaceutical Market Report & Forecast: 2012-2017
10/10/2012 | published by: IMARC
... would impact the course of its growth. These transitions include a shift of growth from the developed to the emerging markets, an increasing focus on biopharmaceuticals compared to small molecule drugs and an increasing preference ...
|
more...
|
$1,400.00
|
|
|
$4,500.00
|
|
|
$4,500.00
|
|
|
$4,500.00
|
|
|
$22,000.00
|
|
|
$3,500.00
|
< prev 1 2 3 4 5 6 7 8 9 10 next >
|